Profile
Snehal Naik currently holds the position of Chief Development Officer at Equillium, Inc. starting in 2026.
Dr. Naik is also Senior Vice President-Clinical Development at Ventyx Biosciences, Inc. since 2024, with employment at Ventyx Biosciences beginning in 2021.
The education history includes an undergraduate degree from the University of Kentucky and a doctorate from Temple University School of Medicine.
Snehal Naik active positions
| Companies | Position | Start |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2024-01-31 |
| EQUILLIUM, INC. | Corporate Officer/Principal | 2026-04-30 |
Training of Snehal Naik
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University School of Medicine
Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Equillium, Inc.
Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Snehal Naik
















